Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience
- PMID: 27984555
- PMCID: PMC5751886
- DOI: 10.1097/QAI.0000000000001267
Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience
Abstract
Background: Lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women (Option B+) was rolled out in Zimbabwe from 2014, with simultaneous raising of the CD4 treatment threshold to 500 cells per cubic millimeter in nonpregnant/breastfeeding adults and children 5 years and over.
Methods: Lablite is an implementation project in Zimbabwe, Malawi, and Uganda evaluating ART rollout. Routine patient-level data were collected for 6 months before and 12 months after Option B+ rollout at a district hospital and 3 primary care facilities in Zimbabwe (2 with outreach ART and 1 with no ART provision before Option B+).
Results: Between September 2013 and February 2015, there were 1686 ART initiations in the 4 facilities: 91% adults and 9% children younger than 15 years. In the 3 facilities with established ART, initiations rose from 300 during 6 months before Option B+ to 869 (2.9-fold) and 463 (1.5-fold), respectively, 0-6 months and 6-12 months after Option B+. Post-Option B+, an estimated 43% of pregnant/breastfeeding women needed ART for their own health, based on World Health Organization stage 3/4 or CD4 ≤350 per cubic millimeter (64% for CD4 ≤500). Seventy-four men (22%) and 123 nonpregnant/breastfeeding women (34%) initiated ART with CD4 >350 after the CD4 threshold increase. Estimated 12-month retention on ART was 79% (69%-87%) in Option B+ women (significantly lower in younger women, P = 0.01) versus 93% (91%-95%) in other adults (difference P < 0.001).
Conclusions: There were increased ART initiations in all patient groups after implementation of World Health Organization 2013 guidelines. Retention of Option B+ women was poorer than retention of other adults; younger women require attention because they are more likely to disengage from care.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S198-S206. doi: 10.1097/QAI.0000000000001347. J Acquir Immune Defic Syndr. 2017. PMID: 28498190
-
Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.BMC Public Health. 2017 Jul 25;18(1):57. doi: 10.1186/s12889-017-4611-2. BMC Public Health. 2017. PMID: 28743251 Free PMC article.
-
Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.Int Health. 2020 Sep 1;12(5):429-443. doi: 10.1093/inthealth/ihz090. Int Health. 2020. PMID: 31730168 Free PMC article.
-
Early retention among pregnant women on 'Option B + ' in urban and rural Zimbabwe.AIDS Res Ther. 2021 Apr 1;18(1):10. doi: 10.1186/s12981-021-00333-3. AIDS Res Ther. 2021. PMID: 33794957 Free PMC article. Review.
-
Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change.Swiss Med Wkly. 2013 Mar 14;143:w13775. doi: 10.4414/smw.2013.13775. eCollection 2013. Swiss Med Wkly. 2013. PMID: 23519621 Review.
Cited by
-
Measuring retention in HIV care: the impact of data sources and definitions using routine data.AIDS. 2020 Apr 1;34(5):749-759. doi: 10.1097/QAD.0000000000002478. AIDS. 2020. PMID: 32004202 Free PMC article.
-
Incidence and predictors of loss to follow-up among pregnant and lactating women in the Option B+ PMTCT program in Northwestern Ethiopia: a seven-year retrospective cohort study.Front Glob Womens Health. 2023 Jul 17;4:1128988. doi: 10.3389/fgwh.2023.1128988. eCollection 2023. Front Glob Womens Health. 2023. PMID: 37529507 Free PMC article.
-
Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.PLoS Med. 2018 Jun 5;15(6):e1002574. doi: 10.1371/journal.pmed.1002574. eCollection 2018 Jun. PLoS Med. 2018. PMID: 29870531 Free PMC article.
-
Group antenatal care for improving retention of adolescent and young pregnant women living with HIV in Kenya.BMC Pregnancy Childbirth. 2022 Mar 15;22(1):208. doi: 10.1186/s12884-022-04527-z. BMC Pregnancy Childbirth. 2022. PMID: 35291978 Free PMC article.
-
A new cascade of HIV care for the era of "treat all".PLoS Med. 2017 Apr 11;14(4):e1002268. doi: 10.1371/journal.pmed.1002268. eCollection 2017 Apr. PLoS Med. 2017. PMID: 28399160 Free PMC article.
References
-
- World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. [accessed 21/10/15];2013 http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html. - PubMed
-
- Fowler MG, Qin M, Fiscus SA, et al. PROMISE: Efficacy and Saftey of 2 Strategies to Prevent Perinatal HIV Transmission. CROI; 2015. [accessed 12/01/2016]. http://www.croiconference.org/sessions/promise-efficacy-and-safety-2-str....
-
- Ministry of Health, Malawi. Clinical Management of HIV in Children and Adults. Malawi Integrated Guidelines; 2011.
-
- World Health Organization. Global health sector response to HIV, 2000-2015: focus on innovations in Africa: progress report. [accessed 12/01/2016];2015 http://apps.who.int/iris/bitstream/10665/198065/1/9789241509824_eng.pdf?....
-
- Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011 Jul 16;378(9787):282–284. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials